Dr. Vishal Vashistha is a hematologist and medical oncologist at Maimonides Cancer Center. He serves as Cancer Center Medical Director and the Chief of the Division of Hematology/Oncology. Dr. Vashistha completed his internal medicine residency at Cleveland Clinic Foundation and his hematology/oncology fellowship at Duke University Medical Center. Dr. Vashistha is a staunch advocate for patients and works collaboratively with staff to provide the most up-to-date cancer treatments at Maimonides. His research has primarily focused on improving the utilization of novel precision oncology diagnostics, namely comprehensive genomic profiling, in routine cancer care. Dr. Vashistha cares for patients with solid tumors, hematologic malignancies, bone marrow failure syndromes, and other benign hematologic conditions, including thrombotic and bleeding disorders. He has been prescribing and administering systemic therapies, including chemotherapy and immunotherapy, to cancer patients since 2017. Dr. Vashistha is certified in internal medicine, hematology, and medical oncology by the American Board of Internal Medicine (ABIM). He is a member of The American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and Association of Veterans Affairs Hematology/Oncology (AVAHO). He is also a member on the education committee for the Binaytara Foundation.
Areas of Expertise
Hematology & Medical Oncology
Conditions Treated
Solid Tumors
Treatments
Chemotherapy
Immunotherapy
Targeted Therapy
Education
Medical Degree
Ohio State University College of Medicine
Internship
Cleveland Clinic Foundation
Residency
Cleveland Clinic Foundation
Fellowship
Duke University Medical Center
Board
Medical Oncology; Hematology; Internal Medicine
Insurance
Please contact this physician directly to obtain the most up-to-date insurance information. To learn more about if Maimonides accepts your insurance plan, click here.
Redirection Confirmation
You are now leaving Maimo, and will be redirected to the site where you can schedule with this provider.